tradingkey.logo


MDGL

MDGL

435.270USD

-0.840-0.19%
終倀 09/03, 16:00ET15分遅れの株䟡
9.67B時䟡総額
--盎近12ヶ月PER

詳现情報 Madrigal Pharmaceuticals Inc 䌁業名
䌁業情報
䌁業コヌドMDGL
䌚瀟名Madrigal Pharmaceuticals Inc
䞊堎日Feb 06, 2007
最高経営責任者「CEO」Mr. Bill Sibold
埓業員数528
蚌刞皮類Ordinary Share
決算期末Feb 06
本瀟所圚地200 Barr Harbor Dr Ste 400
郜垂WEST CONSHOHOCKEN
蚌刞取匕所NASDAQ Global Select Consolidated
囜United States of America
郵䟿番号19428-2978
電話番号14043809263
りェブサむトhttps://www.madrigalpharma.com/
䌁業コヌドMDGL
䞊堎日Feb 06, 2007
最高経営責任者「CEO」Mr. Bill Sibold
圹員䞀芧
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Director
Director
442.32K
--
Dr. Paul A. Friedman, M.D.
Dr. Paul A. Friedman, M.D.
Director
Director
165.12K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
11.38K
+6.70%
Dr. David Soergel, M.D.
Dr. David Soergel, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
7.54K
--
Mr. Raymond Cheong, M.D., Ph.D.
Mr. Raymond Cheong, M.D., Ph.D.
Independent Director
Independent Director
2.40K
--
Mr. Kenneth M. (Ken) Bate
Mr. Kenneth M. (Ken) Bate
Independent Director
Independent Director
1.91K
--
Ms. Shannon Kelley
Ms. Shannon Kelley
Executive Vice President, Chief Legal Counsel
Executive Vice President, Chief Legal Counsel
--
-100.00%
Mr. James M. Daly
Mr. James M. Daly
Independent Director
Independent Director
--
--
Dr. Jacqualyn (Jackie) Fouse, Ph.D.
Dr. Jacqualyn (Jackie) Fouse, Ph.D.
Independent Director
Independent Director
--
--
Mr. Julian C. Baker
Mr. Julian C. Baker
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Director
Director
442.32K
--
Dr. Paul A. Friedman, M.D.
Dr. Paul A. Friedman, M.D.
Director
Director
165.12K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
11.38K
+6.70%
Dr. David Soergel, M.D.
Dr. David Soergel, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
7.54K
--
Mr. Raymond Cheong, M.D., Ph.D.
Mr. Raymond Cheong, M.D., Ph.D.
Independent Director
Independent Director
2.40K
--
Mr. Kenneth M. (Ken) Bate
Mr. Kenneth M. (Ken) Bate
Independent Director
Independent Director
1.91K
--
収益内蚳
デヌタなし
デヌタなし
事業別
地域別
デヌタなし
株䞻
曎新時刻: Sat, Aug 16
曎新時刻: Sat, Aug 16
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Janus Henderson Investors
9.83%
Baker Bros. Advisors LP
9.61%
Paulson & Co. Inc.
9.37%
RTW Investments L.P.
8.94%
Avoro Capital Advisors LLC
8.41%
他の
53.83%
株䞻統蚈
株䞻統蚈
比率
Janus Henderson Investors
9.83%
Baker Bros. Advisors LP
9.61%
Paulson & Co. Inc.
9.37%
RTW Investments L.P.
8.94%
Avoro Capital Advisors LLC
8.41%
他の
53.83%
皮類
株䞻統蚈
比率
Investment Advisor/Hedge Fund
43.18%
Investment Advisor
33.28%
Hedge Fund
17.09%
Family Office
9.38%
Individual Investor
4.76%
Corporation
2.94%
Research Firm
2.40%
Sovereign Wealth Fund
0.79%
Pension Fund
0.65%
機関投資家保有株
曎新時刻: Tue, Jul 1
曎新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q2
650
23.67M
106.20%
-1.56M
2025Q1
668
23.83M
107.57%
-1.54M
株䞻動向
䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Janus Henderson Investors
2.21M
9.93%
-2.54K
-0.12%
Mar 31, 2025
Baker Bros. Advisors LP
1.98M
8.91%
+2.86K
+0.14%
Jun 20, 2025
Paulson & Co. Inc.
2.10M
9.46%
+57.52K
+2.82%
Mar 31, 2025
RTW Investments L.P.
1.99M
8.98%
--
--
Mar 31, 2025
Avoro Capital Advisors LLC
2.02M
9.11%
-6.78K
-0.33%
Mar 31, 2025
The Vanguard Group, Inc.
1.69M
7.6%
-16.02K
-0.94%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.32M
5.92%
-17.10K
-1.28%
Mar 31, 2025
State Street Global Advisors (US)
758.51K
3.42%
-22.78K
-2.92%
Mar 31, 2025
SQN, L.L.C.
655.54K
2.95%
--
--
Apr 01, 2025
UBS Financial Services, Inc.
290.47K
1.31%
+4.09K
+1.43%
Mar 31, 2025
詳现を芋る
関連ETF
曎新時刻: Tue, Sep 2
曎新時刻: Tue, Sep 2
銘柄名
比率
Virtus LifeSci Biotech Products ETF
1.96%
SPDR S&P Biotech ETF
1.87%
Global X Guru Index ETF
1.31%
Simplify Next Intangible Core Index ETF
1.24%
Direxion Daily S&P Biotech Bull 3X Shares
1.2%
Tema Heart & Health ETF
1%
Goldman Sachs Future Health Care Equity ETF
0.79%
First Trust Innovation Leaders ETF
0.78%
ProShares Ultra Nasdaq Biotechnology
0.74%
Invesco Nasdaq Biotechnology ETF
0.66%
詳现を芋る
Virtus LifeSci Biotech Products ETF
比率1.96%
SPDR S&P Biotech ETF
比率1.87%
Global X Guru Index ETF
比率1.31%
Simplify Next Intangible Core Index ETF
比率1.24%
Direxion Daily S&P Biotech Bull 3X Shares
比率1.2%
Tema Heart & Health ETF
比率1%
Goldman Sachs Future Health Care Equity ETF
比率0.79%
First Trust Innovation Leaders ETF
比率0.78%
ProShares Ultra Nasdaq Biotechnology
比率0.74%
Invesco Nasdaq Biotechnology ETF
比率0.66%
配圓金
過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし
株匏分割
日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし
KeyAI
î™